Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Adaptive radiotherapy for head and neck cancer.

Morgan HE, Sher DJ.

Cancers Head Neck. 2020 Jan 9;5:1. doi: 10.1186/s41199-019-0046-z. eCollection 2020. Review.

2.

Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000-2017.

Sanford NN, Sher DJ, Xu X, Ahn C, D'Amico AV, Aizer AA, Mahal BA.

J Natl Compr Canc Netw. 2020 Jan;18(1):69-79. doi: 10.6004/jnccn.2019.7341.

PMID:
31910381
3.

Head and neck neuroendocrine tumors at a single institution over 15 years.

Bacalao M, Beg MS, Cavuoti D, Zhu H, Sumer B, Myers L, Truelson J, Nedzi L, Sher D, Hughes R, Khan SA.

Clin Case Rep. 2019 Nov 17;7(12):2508-2512. doi: 10.1002/ccr3.2545. eCollection 2019 Dec.

4.

Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.

Sacks R, Law JY, Zhu H, Beg MS, Gerber DE, Sumer BD, Myers LL, Truelson JM, Nedzi L, Sher D, Hughes RS, Khan SA.

Oncology. 2019 Dec 17:1-7. doi: 10.1159/000504651. [Epub ahead of print]

PMID:
31846962
5.

In Reply to Mendenhall et al.

Sher DJ, Timmerman RD, Nedzi L, Ding C, Pham NL, Zhao B, Sumer BD.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):221. doi: 10.1016/j.ijrobp.2019.09.043. No abstract available.

PMID:
31836087
6.

Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.

Sanford NN, Aguilera TA, Folkert MR, Ahn C, Mahal BA, Zeh H, Beg MS, Mansour J, Sher DJ.

J Natl Compr Canc Netw. 2019 Nov 1;17(11):1292-1300. doi: 10.6004/jnccn.2019.7322.

PMID:
31693987
7.

Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning.

Zhang Y, Chiu T, Dubas J, Tian Z, Lee P, Gu X, Yan Y, Sher D, Timmerman R, Zhao B.

Radiat Oncol. 2019 Nov 4;14(1):193. doi: 10.1186/s13014-019-1404-z.

8.

Financial Toxicity and Cancer Therapy: A Primer for Radiation Oncologists.

Schroeder SR, Agusala V, Sher DJ.

Hematol Oncol Clin North Am. 2019 Dec;33(6):1117-1128. doi: 10.1016/j.hoc.2019.08.013. Review.

PMID:
31668210
9.

Particle-Associated Microbial Community in a Subtropical Lake During Thermal Mixing and Phytoplankton Succession.

Schweitzer-Natan O, Ofek-Lalzar M, Sher D, Sukenik A.

Front Microbiol. 2019 Sep 13;10:2142. doi: 10.3389/fmicb.2019.02142. eCollection 2019.

10.

Prevalence of chronic pain among cancer survivors in the United States, 2010-2017.

Sanford NN, Sher DJ, Butler SS, Xu X, Ahn C, Aizer AA, Mahal BA.

Cancer. 2019 Dec 1;125(23):4310-4318. doi: 10.1002/cncr.32450. Epub 2019 Aug 22.

PMID:
31436323
11.

Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015.

Sanford NN, Sher DJ, Butler S, Xu X, Ahn C, D'Amico AV, Rebbeck T, Aizer AA, Mahal BA.

JAMA Netw Open. 2019 May 3;2(5):e193759. doi: 10.1001/jamanetworkopen.2019.3759.

12.

Corrigendum to "Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis" [Lung Cancer, Volume 130 (April) (2019) 162-168].

Foster CC, Rusthoven CG, Sher DJ, Feldman L, Pasquinelli M, Spiotto MT, Koshy M.

Lung Cancer. 2019 Jun;132:159. doi: 10.1016/j.lungcan.2019.04.011. Epub 2019 Apr 26. No abstract available.

PMID:
31031052
13.

Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States.

Sanford NN, Sher DJ, Ahn C, Aizer AA, Mahal BA.

JAMA Oncol. 2019 May 1;5(5):735-737. doi: 10.1001/jamaoncol.2019.0349. No abstract available.

PMID:
30973579
14.

Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.

Foster CC, Rusthoven CG, Sher DJ, Feldman L, Pasquinelli M, Spiotto MT, Koshy M.

Lung Cancer. 2019 Apr;130:162-168. doi: 10.1016/j.lungcan.2019.02.023. Epub 2019 Feb 21. Erratum in: Lung Cancer. 2019 Jun;132:159.

PMID:
30885339
15.

Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.

Sher DJ, Timmerman RD, Nedzi L, Ding C, Pham NL, Zhao B, Sumer BD.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):110-118. doi: 10.1016/j.ijrobp.2019.03.010. Epub 2019 Mar 14.

PMID:
30880269
16.

Timing and Impact of Posttreatment PET/CT After First 6 Months on Patient Management and Outcomes in Oropharyngeal Squamous Cell Carcinoma.

You H, Xi Y, Moore W, Sher D, Sanli Y, Subramaniam RM.

AJR Am J Roentgenol. 2019 Mar 5:1-6. doi: 10.2214/AJR.18.20619. [Epub ahead of print]

PMID:
30835513
17.

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue TT, Weiss J, Yom SS, Holsinger FC.

J Clin Oncol. 2019 Jul 10;37(20):1753-1774. doi: 10.1200/JCO.18.01921. Epub 2019 Feb 27.

PMID:
30811281
18.

Isolated versus combined medial patellofemoral ligament reconstruction for lateral instability of the patella.

An VV, Sivakumar BS, Phan K, Fritsch BA, Sher D.

J Orthop Surg (Hong Kong). 2019 Jan-Apr;27(1):2309499018820698. doi: 10.1177/2309499018820698.

PMID:
30798706
19.

Combining many-objective radiomics and 3D convolutional neural network through evidential reasoning to predict lymph node metastasis in head and neck cancer.

Chen L, Zhou Z, Sher D, Zhang Q, Shah J, Pham NL, Jiang S, Wang J.

Phys Med Biol. 2019 Mar 29;64(7):075011. doi: 10.1088/1361-6560/ab083a.

PMID:
30780137
20.

Trends in Smoking and e-Cigarette Use Among US Patients With Cancer, 2014-2017.

Sanford NN, Sher DJ, Xu X, Aizer AA, Mahal BA.

JAMA Oncol. 2019 Mar 1;5(3):426-428. doi: 10.1001/jamaoncol.2018.6858. No abstract available.

21.

Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling.

Khan SA, Ci B, Xie Y, Gerber DE, Beg MS, Sherman SI, Cabanillas ME, Busaidy NL, Burtness BA, Heilmann AM, Bailey M, Ross JS, Sher DJ, Ali SM.

Head Neck. 2019 Jun;41(6):1928-1934. doi: 10.1002/hed.25634. Epub 2019 Feb 13.

PMID:
30758123
22.

3D radiotherapy dose prediction on head and neck cancer patients with a hierarchically densely connected U-net deep learning architecture.

Nguyen D, Jia X, Sher D, Lin MH, Iqbal Z, Liu H, Jiang S.

Phys Med Biol. 2019 Mar 18;64(6):065020. doi: 10.1088/1361-6560/ab039b.

PMID:
30703760
23.

Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.

Foster CC, Sher DJ, Rusthoven CG, Verma V, Spiotto MT, Weichselbaum RR, Koshy M.

Radiat Oncol. 2019 Jan 28;14(1):18. doi: 10.1186/s13014-019-1222-3.

24.

IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing.

LaVigne AW, Margalit DN, Rawal B, Puzanov M, Annino DJ, Goguen LA, Sher DJ, Schoenfeld JD, Chau NG, Lorch JH, Rabinowits G, Haddad RI, Tishler RB.

Head Neck. 2019 Apr;41(4):959-966. doi: 10.1002/hed.25531. Epub 2019 Jan 8.

PMID:
30620435
25.

Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma.

Sher DJ, Yan J, Day A, Sumer BD, Pham NL, Khan S, Zhu H.

Oral Oncol. 2019 Jan;88:18-26. doi: 10.1016/j.oraloncology.2018.11.004. Epub 2018 Nov 16.

PMID:
30616791
26.

Risk of Unplanned Hospital Encounters in Patients Treated With Radiotherapy for Head and Neck Squamous Cell Carcinoma.

Moore ZR, Pham NL, Shah JL, Nedzi L, Sumer BD, Day AT, Khan SA, Sher DJ.

J Pain Symptom Manage. 2019 Apr;57(4):738-745.e3. doi: 10.1016/j.jpainsymman.2018.12.337. Epub 2019 Jan 3.

PMID:
30610892
27.

Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer.

Tumati V, Hoang L, Sumer BD, Truelson JM, Myers LL, Khan S, Hughes RS, Nedzi L, Sher DJ.

Head Neck. 2019 Feb;41(2):315-321. doi: 10.1002/hed.25457. Epub 2018 Dec 13.

PMID:
30548892
28.

Automated Text Message Reminders Improve Radiation Therapy Compliance.

Tan J, Christie A, Montalvo SK, Wallace C, Yan Y, Folkerts M, Yingling A, Sher D, Choy H, Jiang S, Westover KD.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1045-1052. doi: 10.1016/j.ijrobp.2018.11.050. Epub 2018 Nov 30.

PMID:
30508618
29.

Predicting Lymph Node Metastasis in Head and Neck Cancer by Combining Many-objective Radiomics and 3-dimensioal Convolutional Neural Network through Evidential Reasoning.

Zhou Z, Chen L, Sher D, Zhang Q, Shah J, Pham NL, Jiang S, Wang J.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:1-4. doi: 10.1109/EMBC.2018.8513070.

PMID:
30440295
30.

Pregnancy complications and adverse outcomes in placental chorioangioma: a retrospective cohort analysis.

Dong T, Sher D, Luo Q.

J Matern Fetal Neonatal Med. 2018 Nov 26:1-5. doi: 10.1080/14767058.2018.1548598. [Epub ahead of print]

PMID:
30431372
31.

Commercial Claims-Based Comparison of Survival and Toxic Effects of Definitive Radiotherapy vs Primary Surgery in Patients With Oropharyngeal Squamous Cell Carcinoma.

Sher DJ, Agiro A, Zhou S, Day AT, DeVries A.

JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):913-922. doi: 10.1001/jamaoto.2018.1929.

32.

Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.

Sher DJ, Tishler RB, Pham NL, Punglia RS.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):875-882. doi: 10.1016/j.ijrobp.2018.04.018. Epub 2018 Apr 12.

PMID:
29976499
33.

Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2018 May - Jun;8(3):e185-e186. doi: 10.1016/j.prro.2017.08.002. Epub 2017 Aug 5. No abstract available.

PMID:
29724403
34.

Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival.

Verma V, Sleightholm RL, Rusthoven CG, Koshy M, Sher DJ, Grover S, Simone CB 2nd.

Ann Surg Oncol. 2018 Jul;25(7):2018-2026. doi: 10.1245/s10434-018-6499-1. Epub 2018 May 2.

PMID:
29721724
35.

Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.

Lau SKM, Gannavarapu BS, Carter K, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P.

J Oncol Pract. 2018 Apr;14(4):e211-e220. doi: 10.1200/JOP.2017.025239. Epub 2018 Mar 20.

36.

Prevalence and Survival Impact of Pretreatment Cancer-Associated Weight Loss: A Tool for Guiding Early Palliative Care.

Gannavarapu BS, Lau SKM, Carter K, Cannon NA, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P.

J Oncol Pract. 2018 Apr;14(4):e238-e250. doi: 10.1200/JOP.2017.025221. Epub 2018 Feb 21.

37.

Three-dimensional printer-aided casting of soft, custom silicone boluses (SCSBs) for head and neck radiation therapy.

Chiu T, Tan J, Brenner M, Gu X, Yang M, Westover K, Strom T, Sher D, Jiang S, Zhao B.

Pract Radiat Oncol. 2018 May - Jun;8(3):e167-e174. doi: 10.1016/j.prro.2017.11.001. Epub 2017 Nov 11.

PMID:
29452869
38.

Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.

Stokes WA, Bronsert MR, Meguid RA, Blum MG, Jones BL, Koshy M, Sher DJ, Louie AV, Palma DA, Senan S, Gaspar LE, Kavanagh BD, Rusthoven CG.

J Clin Oncol. 2018 Mar 1;36(7):642-651. doi: 10.1200/JCO.2017.75.6536. Epub 2018 Jan 18.

PMID:
29346041
39.
40.

Hyperplastic Polyps and Gastroduodenal Pseudomelanosis.

Agrawal A, Jain D, Arguello V, Sher D.

Case Rep Gastrointest Med. 2017;2017:4270248. doi: 10.1155/2017/4270248. Epub 2017 Nov 15.

41.

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer.

Sher DJ.

Front Oncol. 2017 Dec 4;7:281. doi: 10.3389/fonc.2017.00281. eCollection 2017. Review.

42.

Risk of contralateral nodal failure following ipsilateral IMRT for node-positive tonsillar cancer.

Gottumukkala S, Pham NL, Sumer B, Myers L, Truelson J, Nedzi L, Khan S, Hughes R, Sher DJ.

Oral Oncol. 2017 Dec;75:35-38. doi: 10.1016/j.oraloncology.2017.10.010. Epub 2017 Oct 24.

PMID:
29224820
43.

David Sher on the Updated ASTRO Guidelines for Oropharyngeal Cancer.

Sher DJ.

Oncology (Williston Park). 2017 Sep 15;31(9):656-8. No abstract available.

44.

Reply to Tumor localization may change the type of adjuvant treatment in gastric cancer.

Stumpf PK, Amini A, Jones BL, Koshy M, Sher DJ, Lieu CH, Schefter TE, Goodman KA, Rusthoven CG.

Cancer. 2017 Dec 1;123(23):4737-4738. doi: 10.1002/cncr.31018. Epub 2017 Oct 5. No abstract available.

45.

Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.

Koshy M, Sher DJ, Spiotto M, Husain Z, Engelhard H, Slavin K, Nicholas MK, Weichselbaum RR, Rusthoven C.

J Neurooncol. 2017 Dec;135(3):529-534. doi: 10.1007/s11060-017-2598-2. Epub 2017 Aug 23.

PMID:
28836140
46.

Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.

Kreinbrink P, Blumenfeld P, Tolekidis G, Sen N, Sher D, Marwaha G.

J Geriatr Oncol. 2017 Sep;8(5):351-355. doi: 10.1016/j.jgo.2017.07.002. Epub 2017 Jul 21.

PMID:
28739159
47.

Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.

Goel R, Moore W, Sumer B, Khan S, Sher D, Subramaniam RM.

AJR Am J Roentgenol. 2017 Aug;209(2):289-303. doi: 10.2214/AJR.17.18301. Review.

PMID:
28731808
48.

Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy.

Koshy M, Malik R, Spiotto M, Mahmood U, Rusthoven CG, Sher DJ.

Lung Cancer. 2017 Jun;108:222-227. doi: 10.1016/j.lungcan.2017.04.006. Epub 2017 Apr 17.

PMID:
28625640
49.

Radiation plus Temozolomide in Patients with Glioblastoma.

Rusthoven CG, Koshy M, Sher DJ.

N Engl J Med. 2017 Jun 1;376(22):2195-2197. doi: 10.1056/NEJMc1704726. No abstract available.

PMID:
28564571
50.

Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.

Stumpf PK, Amini A, Jones BL, Koshy M, Sher DJ, Lieu CH, Schefter TE, Goodman KA, Rusthoven CG.

Cancer. 2017 Sep 1;123(17):3402-3409. doi: 10.1002/cncr.30748. Epub 2017 May 17.

Supplemental Content

Support Center